Clinical Trial Update: Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer [Phase 1]

View source ↗

Summary

Phase I trial evaluating hepatic arterial infusion of melphalan in patients with unresectable liver cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Liver Cancer

Drugs mentioned

• Melphalan (Melphalan)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Liver Cancer, Metastatic Cancer | Phase 1 | Status: COMPLETED